Azithromycin in the Prevention of Lung Injury in Premature Newborn

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 28, 2012

Primary Completion Date

April 13, 2016

Study Completion Date

April 13, 2016

Conditions
Bronchopulmonary Dysplasia
Interventions
DRUG

Azithromycin

the newborn group will receive intravenous azithromycin 10 mg / kg / day once daily for 5 days

DRUG

Placebo

the group of newborns will receive 0.9% saline once daily for 5 days

All Listed Sponsors
lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT03485703 - Azithromycin in the Prevention of Lung Injury in Premature Newborn | Biotech Hunter | Biotech Hunter